AUG 07, 2018 10:00 PM PDT

Renal Cell Carcinoma and Myelodysplastic Syndrome Show Epigenetic Association

WRITTEN BY: Mauri Brueggeman

Hypermethylation has been documented in some myeloid disorders including myelodysplastic syndrome (MDS) and in renal cell carcinoma (RCC).  A group at the Mayo Clinic noticed the epigenetic marking patterns between these vastly different conditions and wondered if there was a connection.  The group found that there was a strong association.

Epigenetics, as a field, is being embraced and has been studied for numerous years.  The term “epigenetics” has been around for nearly three quarters of a century, being coined in 1942 by a British developmental biologist named C.H. Waddington.  Some of the genetic underpinnings of heritable changes in gene expression are known but much, as of yet, is less well understood.  Studies have shown that the modification of gene expression results in a variety of conditions that can be congenital or acquired.  The most studied epigenetic change is DNA methylation whereby a methyl group is covalently transferred to the C-5 position of the cytosine ring within a strand of DNA.  DNA methylation can occur within any area of the genome on any given cytosine in mammals; however, most of the methylation takes place in CpG dinucleotide regions which are sequences of DNA with a cytosine (C) nucleotide followed by guanine (G) molecule connected by a phosphodiester bond (“p”).  

In RCC and some myeloid cancers, there is atypical DNA hypermethylation in those CpG regions within tumor suppressor gene promotor regions which inactivate many cellular pathways which lead to cancer.  The researchers at the Mayo Clinic used an explorer database and the Dusseldorf MDS registry to identify patients with a history of both RCC and hematologic malignancies including MDS.  They analyzed clinical features and long-term outcomes; 59 patients were identified as having both RCC and a myeloid malignancy history.  Out of the total, 38 of 59 patients had MDS diagnoses; there was a predominant male to female ratio with a nearly 4.5 times likelihood of a male versus female developing a myeloid malignancy after RCC.  The researchers documented a strong association between RCC and MDS with RCC being the initial diagnosis at a median age of 64 with further development of a MDS in their mid-seventies.  The group concluded that patients with a history of RCC appear to have a significant risk of a MDS emerging later in life compared to the overall population.

Sources: Clinical Genitourinary Cancer,  Cold Spring Harbor Perspectives, Environmental Health Perspectives, Genes and Cancer, Oncogene,

About the Author
  • Mauri S. Brueggeman is a Medical Laboratory Scientist and Educator with a background in Cytogenetics and a Masters in Education from the University of Minnesota. She has worked in the clinical laboratory, taught at the University of Minnesota, and been in post secondary healthcare education administration. She is passionate about advances and leadership in science, medicine, and education.
You May Also Like
APR 24, 2021
Technology
'Information Theory' Detects Culprit Cancer Genes
APR 24, 2021
'Information Theory' Detects Culprit Cancer Genes
A team of scientists at Johns Hopkins used “information theory” to uncover key cancer genes. One such culpri ...
MAY 03, 2021
Cardiology
Task Force IDs 7 Costly Medical Procedures With No Benefit
MAY 03, 2021
Task Force IDs 7 Costly Medical Procedures With No Benefit
Researchers have identified a surprising number of health screens that are given to patients who may not need them. Thes ...
JUN 07, 2021
Cell & Molecular Biology
Overcoming Challenges to Detect Apoptosis in 3D Cell Structures
JUN 07, 2021
Overcoming Challenges to Detect Apoptosis in 3D Cell Structures
Researchers are increasingly relying on cells grown in three-dimensional (3D) structures to help answer their research q ...
JUN 14, 2021
Cell & Molecular Biology
Can An Omega-3 Fatty Acid Destroy Tumors?
JUN 14, 2021
Can An Omega-3 Fatty Acid Destroy Tumors?
The body needs fatty acts for a variety of functions, and the health benefits of taking fatty acid supplements have long ...
JUN 12, 2021
Cancer
Using astronomy to image cancer tumors
JUN 12, 2021
Using astronomy to image cancer tumors
In an interdisciplinary breakthrough, a recent study published in Science describes the development of a new platform, d ...
JUN 21, 2021
Cancer
Analyzing breast implant topography and associated immune responses
JUN 21, 2021
Analyzing breast implant topography and associated immune responses
In an effort to understand how breast implants influence the immune system, researchers from MIT have led an analysis to ...
Loading Comments...